This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Evidence, Mechanisms, and Implications

Myron H. Weinberger, MD

Arch Intern Med. 1985;145(6):1102-1105.

Abstract
• Elevations in the levels of total serum cholesterol, triglycerides, and low-density lipoproteins increase the risk of coronary artery disease and atherogenesis. High-density lipoproteins (HDLs) are beneficial in removing lipid from tissues. High-risk men adhering to a diet and/or receiving cholestyramine to lower their elevated lipid levels had lowering of cardiac mortality. Hypertension is also a major risk factor for cardiovascular disease and for accelerated atherosclerosis. The benefit of blood pressure reduction may not be consistent in decreasing cardiovascular morbidity and mortality among all mildly hypertensive persons. Many antihypertensive agents may raise undesirable lipid fractions and/or lower HDL levels, enhancing the risk of cardiovascular disease, while others have few negative effects. Thus, the antihypertensive agent chosen may modify lipid levels and cardiovascular risk in hypertensive patients.

(Arch Intern Med 1985;145:1102-1105)

Author Affiliations
From the Hypertension Research Center, Indiana University School of Medicine, Indianapolis.

Footnotes
Accepted for publication Oct 25, 1984.

Reprint requests to Hypertension Research Center, Room 477, 541 Clinical Dr, Indianapolis, IN 46223 (Dr Weinberger).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

References
Circulation 2002;106:3373-3421.
FULL TEXT  

Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients
Formiga et al.
Lupus 2001;10:359-363.
ABSTRACT  

Exercise and Weight Loss Reduce Blood Pressure in Men and Women With Mild Hypertension: Effects on Cardiovascular, Metabolic, and Hemodynamic Functioning
Blumenthal et al.
Arch Intern Med 2000;160:1947-1958.
ABSTRACT | FULL TEXT  

Trends in Pharmacologic Management of Hypertension in the United States
Manolio et al.
Arch Intern Med 1995;155:829-837.
ABSTRACT  

Recent Evidence on Drug Therapy of Mild to Moderate Hypertension and Decreased Risk of Coronary Heart Disease
Hebert et al.
Arch Intern Med 1993;153:578-581.
ABSTRACT  

Do No Harm: Antihypertensive Therapy and the J Curve
Weinberger
Arch Intern Med 1992;152:473-476.
ABSTRACT  

The Treatment of Mild Hypertension Study: A Randomized, Placebo-Controlled Trial of a Nutritional-Hygienic Regimen Along With Various Drug Monotherapies
The Treatment of Mild Hypertension Research Group
Arch Intern Med 1991;151:1413-1423.
ABSTRACT  

The Effects of Low Doses of n-3 Fatty Acid Supplementation on Blood Pressure in Hypertensive Subjects: A Randomized Controlled Trial
Radack et al.
Arch Intern Med 1991;151:1173-1180.
ABSTRACT  

Topical Timolol Decreases Plasma High-Density Lipoprotein Cholesterol Level
Coleman et al.
Arch Ophthalmol 1990;108:1260-1263.
ABSTRACT  

Dietary Sodium Restriction as Adjunctive Treatment of Hypertension
Weinberger et al.
JAMA 1988;259:2561-2565.
ABSTRACT  

Statement on Hypertension in Diabetes Mellitus: Final Report
The Working Group on Hypertension in Diabetes
Arch Intern Med 1987;147:830-842.
ABSTRACT  

Thiazides Do Not Cause Long-term Increases in Serum Lipid Concentrations
Burris and Freis
Arch Intern Med 1985;145:2264-2266.
ABSTRACT